Clinical Trial of Telenursing for Monitoring Supportive Care Needs in Patients With Lung Cancer and Melanoma Candidates for the First Prescription of Targeted Therapies

Summary

Single-center, randomized clinical trial (RCT) with low intervention level (Telenursing), for the monitoring of patients affected by lung cancer and melanoma who are candidates for first prescription with Targeted Therapies. The study population will consist of patients suffering from lung cancer and melanoma. The objective of the study will be to evaluate the effectiveness of a Telenursing intervention, comparing the mean score of the total SCNs scale (Supportive Care Needs) after one month of treatment in the treatment arm and in the control arm. Enrolled patients will then be randomized into two treatment arms: * Arm 1 (Control Group): current clinical practice * Arm 2 (Experimental group): Telenursing intervention.

Eligibility

Inclusion Criteria:

* aged between 18 and 75;
* patients suffering from lung cancer and melanoma candidates for the first prescription with Targeted Therapies in exclusive treatment;
* patients able to understand, speak Italian and join the study by signing of paper informed consent;
* possibility of accessing and using the information technologies adopted in trial through a PC/tablet and personal internet connection;
* patients willing to comply with study procedures.

Exclusion Criteria:

* patients not suffering from lung cancer or melanoma;
* patients already treated or currently being treated with Targeted Therapies, or other treatment (chemotherapy and/or radiotherapy and/or exclusive palliative care);
* patients with cognitive problems, psychiatric disorders and poor compliance who could interfere with study participation.

Conditions4

Browse More Trials